MedyMatch’s artificial intelligence-powered clinical decision support tool uses deep learning and patient data to help physicians identify the presence of cerebral bleeding. MedyMatch foresees the technology being deployed in hospital emergency rooms and other acute care settings to aid in the treatment of patients suspected of head trauma or stroke.
The first phase of the collaboration involves IBM Watson Health distributing MedyMatch’s brain bleed detection application. Eventually, the two companies plan to develop interoperability between the MedyMatch application and IBM Watson Health Imaging’s services.
More articles on health IT:
Health IT coalition questions ONC’s mission in letter to Price
Mount Sinai completes mHealth research project on asthma
4 questions with Lahey Health CIO David Reis
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
